221 related articles for article (PubMed ID: 28791678)
1. Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
Jubran R; Kocsis J; Garam N; Maláti É; Gombos T; Barabás L; Gráf L; Prohászka Z; Fishelson Z
Int J Cancer; 2017 Dec; 141(11):2329-2335. PubMed ID: 28791678
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer.
Rozenberg P; Kocsis J; Saar M; Prohászka Z; Füst G; Fishelson Z
Int J Cancer; 2013 Jul; 133(2):514-8. PubMed ID: 23319326
[TBL] [Abstract][Full Text] [Related]
3. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
4. Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection.
Avraham M; Sinkovits G; Hurler L; Prohászka Z; Fishelson Z
Front Immunol; 2024; 15():1337215. PubMed ID: 38715618
[TBL] [Abstract][Full Text] [Related]
5. High serum Hsp70 level predicts poor survival in colorectal cancer: Results obtained in an independent validation cohort.
Gráf L; Barabás L; Madaras B; Garam N; Maláti É; Horváth L; Prohászka Z; Horváth Z; Kocsis J
Cancer Biomark; 2018; 23(4):539-547. PubMed ID: 30452400
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
[TBL] [Abstract][Full Text] [Related]
7. Mortalin expression in pancreatic cancer and its clinical and prognostic significance.
Cui X; Li Z; Piao J; Li J; Li L; Lin Z; Jin A
Hum Pathol; 2017 Jun; 64():171-178. PubMed ID: 28412209
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
[TBL] [Abstract][Full Text] [Related]
9. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.
Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 70 is a useful marker for predicting colorectal cancer.
Gunaldi M; Kocoglu H; Okuturlar Y; Gedikbasi A; Karabulut M; Alis H; Hursitoglu M
J BUON; 2015; 20(6):1464-70. PubMed ID: 26854442
[TBL] [Abstract][Full Text] [Related]
12. Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer.
Sun J; Che SL; Piao JJ; Xu M; Chen LY; Lin ZH
Tumour Biol; 2017 Mar; 39(3):1010428317695918. PubMed ID: 28349826
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Preoperative Serum Carbohydrate Antigen 19-9 in Patients With Stage IV Colorectal Cancer.
Ozawa T; Ishihara S; Kawai K; Nozawa H; Yamaguchi H; Kitayama J; Watanabe T
Clin Colorectal Cancer; 2016 Dec; 15(4):e157-e163. PubMed ID: 27245559
[TBL] [Abstract][Full Text] [Related]
14. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
[TBL] [Abstract][Full Text] [Related]
15. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
16. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
[TBL] [Abstract][Full Text] [Related]
17. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
[TBL] [Abstract][Full Text] [Related]
18. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
20. Is serum placental growth factor a prognostic marker for stage III colorectal cancer patients?
Gomceli I; Tez M; Bostanci EB; Ulas M; Turhan N; Kemik AS; Akoglu M
Hepatogastroenterology; 2012; 59(117):1437-40. PubMed ID: 22155858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]